| abstract |
The present invention provides the beta-lactoglobulin protein and beta-lactoglobulin derived bioactive peptides from the whey fraction of goat milk and antiviral uses thereof, is preventive from infectious diseases and have effects of disease prevention and immune system by affecting on the entry gates of other types of coronaviruses [SARS CoV 2 besides SARS CoV and MERS]. Within the scope of the invention, ALPMHIR (SEQ ID NO:1), GLDIQK (SEQ ID NO:2), TPEVDK (SEQ ID NO:3), IPAVFK (SEQ ID NO:4), EALEK (SEQ ID NO:5) and IIAEK (SEQ ID NO:6) peptides are presented for use in the prevention and also potential treatment of infectious diseases, particularly COVID-19 (SARS-CoV-2). |